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Abstract
Introduction: Accurate and objective measurements of physical activity and lower-extremity function are important in health
and disease monitoring, particularly given the current epidemic of chronic diseases and their related functional impairment.
Purpose: The aim of the present study was to determine the accuracy of a handy (lightweight, small, only one stop/start
button) and low-cost (,$75 with its external antenna) Global Positioning System (GPS) data logger/receiver (the DG100) as a
tool to study outdoor human walking in perspective of health and clinical research studies. Methods. Healthy subjects
performed two experiments that consisted of different prescribed outdoor walking protocols. Experiment 1. We studied the
accuracy of the DG100 for detecting bouts of walking and resting. Experiment 2. We studied the accuracy of the DG100 for
estimating distances and speeds of walking.
Results: Experiment 1. The performance in the detection of bouts, expressed as the percentage of walking and resting
bouts that were correctly detected, was 92.4% [95% Confidence Interval: 90.6–94.3]. Experiment 2. The coefficients of
variation [95% Confidence Interval] for the accuracy of estimating the distances and speeds of walking were low: 3.1% [2.9–
3.3] and 2.8% [2.6–3.1], respectively.
Conclusion: The DG100 produces acceptable accuracy both in detecting bouts of walking and resting and in estimating
distances and speeds of walking during the detected walking bouts. However, before we can confirm that the DG100 can
be used to study walking with respect to health and clinical studies, the inter- and intra-DG100 variability should be studied.
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Introduction
There is much scientific evidence that physical activity or
physical fitness can delay or prevent many chronic health condi-
tions [1], and a number of studies show that physical activity or
physical fitness are inversely related to morbidity or mortality
[1,2,3,4,5]. As a result of these relationships, as well as the current
epidemic of chronic diseases and the high prevalence of physical
inactivity, many research studies have been conducted to measure
physical activity and to better understand its relationship with
health and disease. In addition to measuring physical activity, the
evaluation of lower-extremity function is an important goal in the
elderly [6] as well as in the management of patients with chronic
diseases for both diagnosis and rehabilitation purposes, particu-
larly in relation to cardiovascular heart diseases [7], peripheral
artery disease [8] or chronic obstructive pulmonary disease [9].
Lower-extremity function is primarily determined by measuring
walking impairment. Thus, for those working in public health,
clinical and research settings, accurately measuring physical
activity and/or functional limitation is important.
The global positioning system (GPS) is an emerging technique
for the study of physical activity [10] and functional limitations
[11,12,13,14]. The global positioning system has been recently
used to assess walking capacity in patients with multiple sclerosis
[13], peripheral artery disease [11,12] and in patients undergoing
spine surgery [14]. However, despite the multitude of potential
applications related to the technique, the number of studies using
the GPS for health and disease remains very low as compared to
the numerous studies that have used other objective measurements
of physical activity (i.e. accelerometers, pedometers). There are
many reasons for this discrepancy, and they are potentially
associated: i) the lack of specifically designed validation studies, ii)
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different costs and unknown accuracy, and iii) the complex
operation of most of the currently validated GPS devices, which
limit their use by the inexperienced user (such as a patient and/or
an older subject) in perspective of large cohort studies.
In our laboratory, we previously showed that the handheld
Garmin
TM GPS 60 EGNOS-enabled (Garmin Ltd., USA, ,$200)
was accurate in studying outdoor walking in healthy subjects, using
a simple data processing [15]. This GPS device has since been
used in patients with peripheral artery disease to study walking
capacity [11,12]. Nevertheless, the use of such a GPS device is
confined to the research laboratory because the user needs to be
somewhat experienced in handling such devices. For example,
when using the Garmin
TM GPS 60, the user needs to find the
correct page displays for the GPS initialization. Moreover, because
the configuration (WAAS/EGNOS-enabled option, sampling rate,
or data saving/erasing) of the GPS device is performed ‘‘on-line’’
using the appropriate page display, the configuration can be
unintentionally modified by the inexperienced user.
Within the last three years, an increasing number of handy and
very low-cost GPS data logger/receivers (below $100) have been
made commercially available, making them good candidates for
large cohort studies. These GPS data logger/receivers are well-
suited to this purpose because they are lightweight (below 100
grams), because there is only one start/stop button and because the
signal acquisition is given simply by a flashing LED. In addition, all
settings and configuration are performed on a personal computer
before the measurement. It is currently unknown whether such
extremely low-cost GPS data logger/receivers are accurate enough
for health and clinical use. To the authors’ knowledge, only Town-
shend et al. [16] have published a validation study to measure speed,
displacement,andpositionduringhumanlocomotionusingahandy
(easy to use) low-cost GPS receiver (GPS-BT55, Wonde Proud
Technology Co., Ltd., cost approximately $80). However, the GPS
that was usedwasnot a datalogger,and the data had tobestreamed
to a phone, thereby limiting the usefulness of the technique.
Additionally, the study of Townshend et al. was not specifically
designed to address the needs of health and/or clinical studies.
Indeed, it is an important methodological issue to validate a
measurement technique with respect to the final application for
which it is proposed. In view of the potential use of the GPS
technique for health and clinical studies, there are four important
validation steps: i) accurately detecting the physical activity that is
being studied (e.g., walking or running), ii) estimating and
quantifying the data accurately, iii) reliably showing the relevant
parameters associated with the detected physical activity (e.g.,
walking speed and/or distance), and iv) stating the inter-unit
variability of the GPS models that were used.
Our overall aim in this study was to determine the accuracy and
the reliability of a simple GPS data logger/receiver (the
GlobalSatH DG100) during outdoor walking protocols that were
performed by healthy subjects. Specifically, the purpose was to
determine whether the GlobalSatH DG100 could accurately detect
periods of walking and resting and if it could estimate the speed
and distance of the detected walking periods. We hypothesized
that the DG100: i) would accurately detects bouts of walking and
resting during a series of walking and resting bouts and ii) would
accurately estimates the walking distances and speeds of the
detected walking periods. To strengthen the study of the accuracy
of the GlobalSatH DG100, we simultaneously used the previously
validated Garmin
TM GPS 60 for direct comparison. This
comparison was of particular interest because the required
processing methodology of GPS speed signals was validated using
the Garmin
TM GPS 60 [15], and the external validity (use of the
same method with a different device) of this methodology is
unknown.
In the present study, we focused only on walking because
walking is the most typical human physical activity and has been
reported to be a key activity to achieve health benefits [2,3,4,5].
Furthermore, in a clinical context, functional limitations are
mainly evaluated through the measurement of walking limitation.
Methods
Ethics Statement
This study was approved by our institutional ethics committee
(‘‘Comite ´ de Protection des Personnes: OUEST II’’) and registered
in the American National Institute of Health database under
reference nu NCT00485147. For each experiment, the subjects
were informed of the experimental procedure, and written
informed consent was obtained from all participants.
Instrumentation
During all experiments, we used the GlobalSatH DG100 GPS
data logger/receiver (GlobalSat Technology Corp., Taiwan, cost
approximately $60) with its external antenna (AT-65 GPS Active
Antenna; GlobalSat Technology Corp., Taiwan, cost approxi-
mately $15), and the Garmin
TM GPS 60 (Garmin Ltd., USA, cost
approximately $200), also with its external antenna (GA 25MCX,
Garmin Ltd., USA, cost approximately $30). Throughout the
paper, the following abbreviations are used to facilitate reading:
‘‘DG100’’ (GlobalSatH DG-100 GPS) and ‘‘GPS60’’ (Garmin
TM
GPS 60).
The DG100 is a convenient (see introduction) and inexpensive
data logger that includes the ‘‘European Geostationary Navigation
Overlay Service’’ (EGNOS) function. Technical details of the
DG100 can be found on the manufacturer’s website (www.
globalsat.com.tw). The GPS60 also has the EGNOS function and
has been previously validated to study outdoor human walking
[15], and has since been used in clinical studies [11,12]. However,
because of its lack of practicality (see introduction), it cannot be
used for large cohort studies. The technical details of the GPS60
can also be found on the manufacturer’s website (www.garmin.
com). The principles of GPS and EGNOS-enabled GPS have
been well-described elsewhere, and to avoid redundancy, we refer
readers to the previous articles for detailed explanations
[10,17,18].
The chosen recording rate for both the DG100 and the GPS60
device was 0.5 Hz, as in our previous studies [11,12,15]. During
all experiments, both the DG100 and the GPS60 were placed in a
backpack, and their antennas were placed over the backpack that
was worn by the subjects.
Experiment 1: accuracy of detecting bouts of walking &
resting
Objective. In Experiment 1, we explored the accuracy of the
DG100 in the detection of bouts of outdoor walking and resting of
different durations from prescribed walking protocols (PWPs)
performed by healthy subjects. The accuracy of the DG100 was
compared to the accuracy of the GPS60.
Prescribed walking protocols. Experiment 1 consisted of
10 different PWPs performed at a ‘‘usual’’ walking pace and at a
‘‘slow’’ walking pace, thus resulting in the recording of 20 trials. By
performing the 10 PWPs at two different walking paces, we
expected to cover a larger range of walking speeds than if we had
asked the subjects to walk at only a freely chosen speed. The
‘‘usual’’ pace meant that the subjects were asked to walk at their
typical self-selected pace. For the ‘‘slow’’ walking pace, the subjects
DG100 Accuracy for Clinical Studies
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paces, the subjects were asked to keep their pace as constant as
possible throughout the PWPs.
Each of the 10 PWPs included a randomized succession of 21
bouts of walking alternating with 20 bouts of resting. Based on the
results of our previous study [15], our aim was to include a
relatively large number of bouts of short duration. Indeed, we
showed that these short bouts are responsible for most of the
events that were incorrectly detected. Thus, the chosen bout
durations of both walking and resting PWPs were 6, 8, 10, 12, 14,
16, 30, 60, 120, 240, 480 & 960 s. Once a random sample of 21
walking and 20 resting durations (different for each PWP) was
available, a drawing of lots was performed to define the order of
the walking and resting durations for each PWP. Once the PWPs
were developed, one of the investigators recorded audio files using
an MP3 player. A single audio file recorded the oral directions for
the entire duration of each PWP (e.g. ‘‘you will start soon’’, ‘‘walk’’,
‘‘keep walking’’, ‘‘you will stop soon’’, ‘‘stop’’, and ‘‘stay still’’) at
intervals consistent with each pre-defined PWP.
Experimental procedure. Fifteen healthy subjects (F/
M=6/9; 2467 years, 17167 cm and 6565 kg) participated in
Experiment 1. Prescribed walking protocols were performed in a
designated public park in Angers, France (latitude: 47u 289 220
North; longitude: 0u 329 530 West). This public park is a flat area
(no hills) and is free of motorized vehicles, buildings and dense
trees. All of the experiments were performed under the supervision
of an investigator. Throughout all of the experiments, the
investigator waited for the time needed for the two GPS devices
to initialize before the experiments could start. The subjects were
equipped with the two GPS devices and the MP3 player. The
subjects were blind to the PWPs time-course. Throughout the
PWPs, the investigator walked ,10 m behind the subjects and
reported any potential external events that could interfere with the
PWPs. At the end of the PWPs, the subjects waited for about
2 min (stationary position) and the investigator stopped the GPSs
recordings.
GPS data processing and analysis. After each experiment,
the data were downloaded from the DG100 using the GlobalSat
software utility (Data logger PC utility, version 1.1, 2006, Taiwan).
The data for the GPS60 were downloaded using the MapSourceH
software (Version 6, Garmin Ltd., USA). The data were
automatically expressed in speed by these programs. The speed
values that were obtained were analyzed on a personal computer
using a spreadsheet (MicrosoftH Excel 2000, Microsoft
Corporation, USA) and the specific processing methodology that
we had previously validated [15]. Using this methodology with the
GPS60, we had previously reported the accuracy of detecting
bouts of walking and resting to be 97.1% when only a few bouts of
less than 30 s were prescribed in the PWPs. Additionally, the
estimation of the distance and speed walked was highly accurate
(r=1 between the actual and the processed distances and r=0.97
between the actual and the processed speeds).
Statistical analyses. To determine the accuracy of the
DG100 in detecting bouts of walking and resting and compare it
with the accuracy of the GPS60, we performed a ‘‘bout-level
analysis’’ that simply relied on the comparison of the prescribed
and the detected bouts [15]. Using this procedure, the final
analysis was to calculate the accuracy of both the DG100 and the
GPS60 in the detection of bouts of walking and resting that were
actually performed. For this purpose, the number of incorrectly
detected bouts was calculated. A bout was reported to be
incorrectly detected if i) one false bout of walking (or more)
occurred during an actual bout of resting, ii) one false bout of
resting (or more) occurred during an actual bout of walking, iii) the
time difference, expressed as a percent error between the actual
and the detected bout time, exceeded +/220%. For instance, if a
detected bout that was estimated by analysis to last 8 s actually
lasted 14 s, it was reported to be incorrectly detected (error
percentage =243%). Three investigators performed the GPS
analyses and were blind to the time-course of the PWPs and the
walking pace modality.
The accuracy of bout detection for each GPS device is reported
with 95% Confidence Intervals (95% CI). Between-GPS device
comparison of the accuracy of bout detection was performed using
the MacNemar test. The percent error for the time difference
between the actual and detected bouts (expressed as an absolute
value) was also compared between the DG100 and the GPS60.
Because the data did not assume a Gaussian distribution, we used
the Mann-Whitney test. The statistical analysis was performed
with SPSS statistical software (version 17.0, 2008, SPSS Inc.,
USA). A p-value ,0.05 was considered as statistically significant.
Experiment 2: accuracy of estimating distances and
speeds of walking
Objective. In Experiment 2, we determined the accuracy of
the DG100 in the estimation of outdoor walking distances and
speeds from other PWPs performed by healthy subjects.
Prescribed walking protocols. Experiment 2 consisted of
the recording of an additional 10 PWPs. Each PWP consisted of a
series of walking bouts of 50, 100, 150, 200, 250, 300, 350 and
400 m (total distance: 1800 m). The order of the bouts of walking
within the PWPs was predetermined randomly. Throughout all
the PWPs, each walking bout was separated by a resting period of
,30 s. The subjects were asked to alternately perform the PWP
two times at a ‘‘usual’’ pace and two times at a ‘‘slow’’ pace.
Experimental procedure. Ten healthy subjects (3265
years, 17368 cm and 6769 kg) took part in Experiment 2. The
prescribed walking protocols were performed on a 400 m outdoor
athletic track in Angers, France (latitude: 47u 289 220 North;
longitude: 0u 329 530 West). Eight blocks were placed every 50 m
on the 400 m outdoor athletic track. The subjects were asked to
walk on the interior lane of the athletic track and to stop at the
next block when they heard a whistle blown by the investigator.
The investigator whistled when the subject was approximately ten
meters away from the block where the subject was expected to
stop. The actual speed over each bout of walking was calculated by
dividing the actual distance traveled by the time measured by
chronometry (Geonaute Trt’L 500, Decathlon Ltd., France). For
each PWP, the recording was started on the athletic track with the
recording of the time and validation of an event marker.
GPS data processing and analysis. The GPS data proce-
ssing and analysis follows the same procedures as described above
for Experiment 1.
Statistical analysis. The accuracy of the DG100 and the
GPS60 measurements was determined by calculating the following
for each device according to the statistical procedure proposed by
Hopkins [19]: i) the typical error of the estimated accuracy (TEE)
and ii) the coefficient of variation of the accuracy (CV). This
statistical procedure relied on the comparison of the GPS distances
and speeds with the actual distances and speeds. To standardize
and facilitate the method of TEE and CV calculations, we used the
spreadsheet proposed by Hopkins [20]. Because we also calculated
the TEE and CV for each distance (50, 100, etc…, up to 400 m),
we could not use the ‘‘validity spreadsheet’’ proposed by Hopkins
[21]. As suggested by Hopkins (personal communication), we used
‘‘the reliability spreadsheet’’ and we carefully deleted the term
‘‘!2’’ from the TEE and CV calculation formulas [20]. TEE and
CV are presented with 95% Confidence Intervals. Further, the
DG100 Accuracy for Clinical Studies
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the variance of each CV and for the ratio of the larger variance to
the smaller variance between the two GPS devices. Finally, we
calculated a p-value from the variance ratio according to the F
distribution [22]. A p-value ,0.05 was considered as statistically
significant.
Results
No external event interfered with any of the experiments
performed.
Experiment 1
We investigated the accuracy of the DG100 for detecting bouts of
outdoor walking and resting of different durations from PWPs. The
accuracy of the DG100 was compared to the accuracy of the GPS60.
The total recording time that was analyzed for each GPS device
was 1540 min (,25.7 hours). A sufficient number of satellite
signals were always available for the DG100 because no GPS
signal lost was present in the recordings. Among the 1540 min of
recordings for the GPS60, only one episode of undetectable
satellite signal was noted lasting 0.97 min. Mean 6 standard
deviation of walking speed for the DG100 was 2.760.4 km/h
(range 1.9 to 3.3 km/h) for ‘‘slow’’ pace PWPs, and was
4.660.6 km/h (range 3.4 to 5.1 km/h) for ‘‘usual’’ pace PWPs.
The accuracy in the detection of bouts for the DG100 was high,
92.4% [90.6%–94.3%]. The accuracy in the detection of bouts for
the GPS60 was 77.0% [74.1%–79.8%] and was significantly lower
than the accuracy that was reported for the DG100 (p,0.001).
Figure 1 shows a typical example of the GPS-processed speed
data that was obtained from the same PWP for each GPS device. It
was interestingto observe that the walking speed during the bouts of
walking seemed more variable for the GPS60 as compared to the
DG100. The graphs in Figure 2 show the percent error for the time
difference between the actual and the detected bouts according to
the actual bout time for each GPS device. As shown, the percent
error increased when the actual bout time decreased. Interestingly,
most of the error corresponded to bouts of walking that lasted #30 s
and especially to bouts that were #15 s. The percent error tended
to be higher for the GPS60 and lower for the DG100 on both sides
of the x-axis. The percent error was significantly lower for the
DG100 as compared to the GPS60 (non-parametric test, P,0.001).
Experiment 2
The aim was to determine the accuracy of the DG100 when
estimating the distance and speed of outdoor walking from other
PWPs. The accuracy of the DG100 was compared to the accuracy
of the GPS60. A sufficient number of satellite signals were always
available for the DG100. For the GPS60, only one episode of
undetectable satellite signal that lasted 2.72 min was noted during
one PWP, leading to the exclusion of two bouts of walking from
the statistical analysis. Mean 6 standard deviation of walking
speed for the DG100 was 3.260.9 km/h (range 1.4 to 4.8 km/h)
for ‘‘slow’’ pace series, and was 5.560.6 km/h (range 4.1 to
6.8 km/h) for ‘‘usual’’ pace series. Table 1 presents the TEE and
CV of the estimated walking distances and speeds for each GPS
device. As shown, when considering all pooled distances the values
for the DG100 were better (lower CV) when compared to those of
the GPS60 (p,0.001).
Discussion
This study provides original results about the accuracy of a
handy GPS data logger/receiver, the DG100, in order to study
outdoor human walking for health and clinical research studies.
There were two major findings of the present study. First, the
DG100 is accurate for the detection of bouts of walking and
resting. Second, it estimates with accuracy the speed and distance
of walking. It should be noted that in all cases, the DG100
performed better than the GPS60. Although it was not a primary
goal of the study, this is of particular interest because the data
processing that was used here was previously developed and
validated for the GPS60 device. This study confirms the robustness
of the previously validated processing method and its external
validity.
Accuracy of the DG100 GPS to study human outdoor
walking
The detection of bouts of walking and
resting. Surprisingly, very few studies have addressed this
issue or the detection of other physical activities using the GPS.
However, when quantifying a physical activity, or more specifi-
cally, when studying outdoor walking as in the present study,
accurately detecting periods of walking is a major issue and a
necessary first step, particularly for medical applications [11,
12,15]. Troped et al. [23] showed that the addition of GPS to
accelerometer monitoring slightly improved the classification of
physical activity, particularly for walking. A direct comparison of
our results with the study of Troped et al. remains difficult because
i) the GPS data analysis was performed from the GPS dataset
composed of minute-by-minute observations (every 2 s here) and
ii) the authors only focused on the detection of bouts of walking.
The results of the present study can be compared directly to our
previous study that focused on the accuracy of the GPS60 for the
detection of bouts of walking and resting [15]. We reported the
accuracy at the bout level to be 97.1% (95% CI, 93.5–98.8) using
the same study design and the same GPS data processing
methodology [15]. This is considerably higher than the accuracy
that was reported in the present study. This is not surprising
because the PWPs that were performed in the present study
voluntarily included a high proportion of short bouts as compared
to our previous study [15], and errors in the detection of bouts
arise primarily from the incorrect detection of shorts bouts
(Figure 2).
The estimation of walking distances and speeds. It
should be pointed out that the present study aimed to assess the
accuracy of the GPS for the estimation of walking distances and
speeds and not to assess the positional accuracy (i.e., statistical
accuracy), which is of little interest in view of our final clinical
application. The results of the accuracy of estimating walking
distancesand speedsthat arereported inthepresent study are within
the range of the results that are reported in validation studies that
focused specifically on walking and that have been carried out since
the selective availability was turned off in May 2000
[15,16,24,25,26]. Selective availability refers to the automatic and
deliberate degradation of the satellites’ signals by the U.S.
Department of Defense before May 2000. Using a nondifferential
GPS device during 40 bouts of walking that were 100 m long,
Townshend et al. [16] reported an error in the estimation of walking
distances less than 0.50 m.As compared to both our present and our
previous study [15], in which we also performed bouts of walking
that were 100 m long, the accuracy reported by Townshend et al.
was particularly high. However, this high accuracy in estimating the
distances of walking did not translate into a particularly high
accuracy for the estimation of speeds (walking and running) as
compared to the other available studies [15,25].
Others studies that were designed for sports applications have
used sport-specific GPS devices to assess different movement
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that most of these studies used relatively expensive devices that
analyzed a combination of GPS-signal and accelerometry. These
devices used algorithms that retrieve data from the built-in high-
frequency accelerometer to correct 1 Hz or 5 Hz GPS values,
which is expected to improve the accuracy of the GPS devices.
Consequently, it is difficult to comment on the ‘‘real’’ accuracy of
the GPS devices for the estimation of speed and distance. Using
the WI SPI elite GPS (GPSports, Canberra, ACT, Australia), Gray
et al. [29] reported a mean total distance error of 5.8 m when
walking over a straight 200-m path, which is consistent with the
results that were reported in the present study with the DG100
(Table 1). Interestingly, over very short distances of 10, 20 and
40 m, Jennings et al. [28] studied the validity of using two
MinimaxX GPS devices simultaneously, with sampling rates of
1 Hz and 5 Hz respectively. With the 1 Hz sampling rate, the
authors reported a standard error of the estimate of 23.8, 17.4 and
9.6% for 10, 20 and 40 m, respectively. With the 5 Hz device, the
authors reported CVs of 21.3, 16.6 and 9.8% for 10, 20 and 40 m,
respectively. These results indicate that there is probably little
benefit to using a GPS device with a sampling rate higher than
1 Hz if only walking locomotion is studied. For instance, in the
Figure 1. A typical example of GPS processed speed data obtained from a prescribed outdoor walking protocol, both for the
DG100 and the GPS60. The entire PWP is not represented on the graph to simplify the figure. The period represented on the graph lasts ,24 min
(from minute 34.2 to minute 58.3).
doi:10.1371/journal.pone.0023027.g001
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CV of 4.2% for a 50 m walking distance estimation. Finally, over a
walking distance of 8800 m, Petersen et al. [27] reported a
standard error of the estimate ranging between 0.6% and 3.8%,
for the five GPS devices that were tested.
DG100 vs. GPS60: technical considerations for the user
Experiments 1 and 2 clearly indicated that the DG100 was
more accurate than the GPS60. Although we did not specifically
study the reasons for such differences, the comparison shows that
the GPS model used has important consequences. One potential
explanation is the type of chipset that was present in the GPS
devices. The GPS60 is built with a SiRF II chipset, whereas the
DG100 is built with a SiRF III chipset. One of the expected
advantages of the SiRF III chipset is a higher sensitivity for
improved locking of satellite signals in low signal areas and this
could explain the higher accuracy that was found for the DG100
in this study. Thus, when possible, users should prefer GPS devices
that are built with the more recent chipsets, such as the SiRF III
chipset. A possible consequence of this technological difference is
the lower variation in walking speeds that was observed with the
DG100 (Figure 1). It is likely that wider variation in walking speeds
Figure 2. Graphical representation for both the DG100 and the GPS60, of the error percentage for time difference between actual
and detected bouts according to actual bout time. Note: concentrations of point near 0% for the DG100 give the impression that there were
fewer points, particularly for bouts less than 0.5 min. This was not the case. For instance, there were 65 and 70 bouts of 0.17 min (10 s) for the GPS60
and the DG100, respectivel.
doi:10.1371/journal.pone.0023027.g002
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accuracy of detection of the GPS60, particularly when the walking
speed was slow. When we calculated the coefficient of variation of
the processed walking speeds among each bout of walking that was
accurately detected, we found a wider variation of walking speeds
for the GPS60 as compared to the DG100 (results not shown).
However, it is important to realize that the accuracy of the GPS
does not only depend on the type of chipset. The precision of the
algorithm used by the software to convert and correct raw data
probably also accounts for an important part in the accuracy of a
GPS device. These algorithms are, unfortunately, considered to be
proprietary.
The fact that the accuracy of the GPS60 was considerably lower
than the DG100 does not imply that it is not accurate for the study
of outdoor walking. The accuracy of the GPS60 is lowest on shorts
bouts (i.e. bouts #30 s and particularly bouts #15 s), as previously
reported [15]. Depending on the final application, such shorts bouts
of walking and/or resting, may, or may not be of clinical interest.
For instance, most patients with vascular intermittent claudication
have stops induced by lower-limb pain that last approximately
2 min [12]. However, in patients with impaired ambulation from
hemiparetic stroke, the ability to perform short bouts of walking .5
steps can be an outcome measure that is assessed [30]. Thus, in such
clinical context, the DG100 should be preferred.
Other important considerations for users when using a GPS
device are the choice of the sampling rate when configuring the
GPS and the use of the WAAS/EGNOS function. In the present
study, we used a sampling rate of 0.5 Hz, as in our previous studies
[11,12,15]. It is important to note that the processing methodology
of the GPS speed signals we used for the detection of bouts of
walking and non-walking was initially developed with a sampling
rate of 0.5 Hz [15]. If required, this methodology could be used
with a 1 Hz sampling rate. For slow displacements such as
walking, a 0.5 Hz sampling rate is sufficient. However, if one
would assess bursts displacements over bouts of short duration, a
sampling rate of 1 Hz and higher should be preferred.
The WAAS/EGNOS function improves the determination of
position by collecting error-correction data from multiple
reference stations via terrestrial communications [31,32]. The
error-correction data are transmitted to an additional ‘‘geosta-
tionary earth orbit satellite’’, after which they are re-transmitted to
the GPS receiver. The WAAS system works in North America,
whereas the EGNOS system works in Western Europe. According
to the Federal Aviation Administration (http://www.faa.gov), the
accuracy in positional estimation using the WAAS system is
approximately seven meters. The official EGNOS Portal (http://
egnos-portal.gsa.europa.eu) reports that an EGNOS-enabled
receiver can provide location accuracy to within three meters.
This is the accuracy that is typically reported by GPS manufac-
turers. However, there is a lack of studies examining the accuracy
of a WAAS-enabled GPS unit for determining the position, speed
and distance of human locomotion. To the authors’ knowledge,
only Witte and Wilson have addressed this issue, although they
focused only on cycling [32,33]. The authors reported the
distribution of error values and showed that 81% of the values
recorded by the WAAS-enabled unit were within 0.4 m.s
21 vs.
64% for the non-WAAS unit [32,33].
Lastly, two important points need to be considered for health
and clinical research in large cohort studies: the cost and the
practicality of the device. Because of its very low cost (below $100)
and its ease of use (only one start/stop button and signals
acquisition is indicated by a flashing LED), the DG100 is a good
candidate for such studies.
Conclusion
The results of this study indicate that the DG100 produces
acceptable accuracy both in detecting bouts of walking and resting
and in estimating distances and speeds of walking during the
detected periods of walking. Our results show that the accuracy of
the DG100 was better than the accuracy of the GPS60, a
somewhat older GPS device dating back to ,1996. This
additional result suggests that the rapid innovation of GPS
technology is likely to improve the performance of new GPS
devices as compared to older GPS devices, and at a lower cost.
Further studies are needed to address the inter- and intra-DG100
variability.
Table 1. Accuracy of the estimation of processed walking distances and speeds, according to the covered distance, for both the
DG100 and the GPS60; the typical error of the estimate (TEE) and the coefficient of variation (CV) with 95% Confidence Interval
(95% CI) are presented.
Accuracy of the estimation of processed walking distances
1 Accuracy of the estimation of processed walking speeds
2
Distances (m) TEE [95% CI] CV [95% CI] TEE [95% CI] CV [95% CI]
DG100 GPS60 DG100 GPS60 DG100 GPS60 DG100 GPS60
50 2.0 [1.6–2.6] 4.7 [3.8–6.0] 4.2 [3.4–5.4]* 9.7 [7.9–12.7] 0.1 [0.1–0.2] 0.4 [0.4–0.6] 3.4 [2.8–4.4]* 8.9 [7.3–11.6]
100 4.7 [3.8–6.0] 5.4 [4.4–7.0] 5.0 [4.1–6.4] 5.4 [4.4–7.0] 0.2 [0.2–0.2] 0.2 [0.2–0.3] 4.6 [3.8–6.0] 4.5 [3.6–5.8]
150 5.2 [4.2–6.6] 9.9 [8.1–12.7] 3.5 [2.9–4.6]* 6.2 [5.1–8.1] 0.1 [0.1–0.1] 0.2 [0.1–0.2] 3.4 [2.7–4.3]* 5.6 [4.6–7.2]
200 4.2 [3.4–5.3] 8.3 [6.8–10.7] 2.1 [1.7–2.7]* 4.0 [3.3–5.2] 0.1 [0.0–0.1] 0.1 [0.1–0.1] 1.7 [1.4–2.1]* 3.6 [2.9–4.6]
250 5.9 [4.8–7.5] 7.3 [6.0–9.4] 2.4 [2.0–3.1] 2.9 [2.3–3.7] 0.1 [0.1–0.1] 0.1 [0.1–0.2] 2.2 [1.8–2.8] 2.6 [2.1–3.4]
300 6.6 [5.4–8.5] 8.8 [7.2–11.4] 2.2 [1.8–2.9] 2.9 [2.4–3.7] 0.1 [0.1–0.1] 0.1 [0.1–0.2] 2.2 [1.8–2.8] 2.6 [2.1–3.4]
350 7.1 [5.8–9.1] 9.7 [8–12.6] 2.0 [1.7–2.6]* 2.7 [2.2–3.5] 0.1 [0.1–0.1] 0.1 [0.1–0.2] 2.4 [1.9–3.0]* 3.3 [2.7–4.3]
400 6.9 [5.7–8.9] 12.9 [10.6–16.5] 1.8 [1.4–2.3]* 3.2 [2.6–4.1] 0.1 [0.1–0.1] 0.1 [0.1–0.2] 1.7 [1.4–2.2]* 3.1 [2.6–4.0]
All pooled distances
(mean distance =225 m)
5.6 [5.2–6.1] 8.9 [8.3–9.7] 3.1 [2.9–3.3]* 5.1 [4.7–5.5] 0.1 [0.1–0.1] 0.2 [0.2–0.2] 2.8 [2.6–3.1]* 4.7 [4.3–5.1]
1For the accuracy of the estimation of processed walking distances, TEE is expressed in meters and CV is expressed in percentage.
2For the accuracy of the estimation of processed walking speeds, TEE is expressed in km.h
21 and CV is expressed in percentage.
For CV values comparisons: * is significantly different from GPS60 (P,0.05).
doi:10.1371/journal.pone.0023027.t001
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